Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status

Journal of the American Heart Association

Volumn 6, Issue 3, 2017, Pages

  Colantonio, Lisandro D ^a   Richman, Joshua S ^b   Carson, April P ^a   Lloyd Jones, Donald M ^c   Howard, George ^a   Deng, Luqin ^a   Howard, Virginia J ^a   Safford, Monika M ^d   Muntner, Paul ^a   Goff, David C ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Kentucky   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiovascular disease; Primary prevention; Risk assessment; Risk factor; Socioeconomic position

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CALIBRATION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOUSEHOLD INCOME; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL ISOLATION; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEMOGRAPHY; EDUCATIONAL STATUS; INCOME; MIDDLE AGED; MORTALITY; RISK FACTOR; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; EDUCATIONAL STATUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCOME; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; SOCIAL CLASS; STROKE; UNITED STATES;

EID: 85032222340     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.005676     Document Type: Article

References (46)

1. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS,Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation. 2014;129:S49-S73.
2. Stone NJ, Robinson JG, Lichtenstein AH, Bairey MERZ CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-S45.
3. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382:1762-1765.
4. Cook NR, Ridker PM. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women'sHealth Study. JAMA Intern Med. 2014;174:1964-1971.
5. Final report on the aspirin component of the ongoing Physicians' Health Study.Steering Committee of the Physicians' Health Study Research Group. N Engl JMed. 1989;321:129-135.
6. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, HennekensCH, Buring JE. A randomized trial of low-dose aspirin in the primary preventionof cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
7. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13: S107-S121.
8. Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311:1406-1415.
9. Lang T, Lepage B, Schieber A-C, Lamy S, Kelly-Irving M. Social determinants of cardiovascular diseases. Public Health Rev. 2012;33:601-622.
10. Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, Davey- Smith G, Dennison-Himmelfarb CR, Lauer MS, Lockwood DW, Rosal M, Yancy CW. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation.2015;132:873-898.
11. Fiscella K, Tancredi D. Socioeconomic status and coronary heart disease risk prediction. JAMA. 2008;300:2666-2668.
12. Brindle PM, McConnachie A, Upton MN, Hart CL. Davey Smith G, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: aprospective study. Br J Gen Pract. 2005;55:838-845.
13. Ramsay SE, Morris RW, Whincup PH, Papacosta AO, Thomas MC, Wannamethee SG. Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: results from astudy in British men. Eur J Cardiovasc Prev Rehabil. 2011;18:186-193.
14. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
15. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308:1768-1774.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
17. Pullicino PM, McClure LA, Wadley VG, Ahmed A, Howard VJ, Howard G, Safford MM. Blood pressure and stroke in heart failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke. 2009;40:3706-3710.
18. Singh GK. Area deprivation and widening inequalities in US mortality, 1969- 1998. Am J Public Health. 2003;93:1137-1143.
19. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, Cushman M, Moy CS, Soliman EZ, Kissela BM, Howard G. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619-627.
20. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio- Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653.
21. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543-2549.
22. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, MA: Wright-OSG; 1982.
23. Prineas RJ, Crow RS, Zhang ZM. Minnesota Code Manual of Electrocardiographic Findings. London, England: Springer-Verlag; 2010.
24. D'Agostino R, Nam B-H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handb Stat. 2004;23:1-25.
25. Colette D. Modeling Survival Data in Medical Research. London, England: Chapman & Hall; 1994.
26. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
27. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
28. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377-399.
29. Stone NJ, Lloyd-Jones DM. The Pooled Cohort equations for predicting risk of myocardial infarction and stroke: validated in representative natural history populations. Mayo Clin Proc. 2016;91:692-694.
30. DeFilippis AP, Young R, Carrubba CJ, McEvoy JW, Budoff MJ, Blumenthal RS, Kronmal RA, McClelland RL, Nasir K, Blaha MJ. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162:266-275.
31. Cook NR, Ridker PM. Calibration of the Pooled Cohort equations for atherosclerotic cardiovascular disease: an update. Ann Intern Med. 2016;165:786-794.
32. Blaha MJ. The critical importance of risk score calibration: time for transformative approach to risk score validation? J Am Coll Cardiol. 2016;67:2131-2134.
33. Fiscella K, Tancredi D, Franks P. Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J. 2009;157:988-994.
34. Ferrario MM, Veronesi G, Chambless LE, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V, Borglykke A, Hart N, Soderberg S, Cesana G. The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: the MORGAM Project Cohort Component. Heart. 2014;100:1179-1187.
35. Rawshani A, Svensson AM, Rosengren A, Eliasson B, Gudbjornsdottir S. Impact of socioeconomic status on cardiovascular disease and mortality in 24,947 individuals with type 1 diabetes. Diabetes Care. 2015;38:1518- 1527.
36. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267- 1278.
37. Guirguis-Blake JM, Evans CV, Senger CA, Rowland MG, O'Connor EA, Whitlock EP. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2015.
38. Brown AF, Gross AG, Gutierrez PR, Jiang L, Shapiro MF, Mangione CM. Incomerelated differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc. 2003;51:665-670.
39. Gamboa CM, Safford MM, Levitan EB, Mann DM, Yun H, Glasser SP, Woolley JM, Rosenson R, Farkouh M, Muntner P. Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease. Am J Med Sci. 2014;348:108-114.
40. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172; discussion 207- 112.
41. Woodward M, Brindle P, Tunstall-Pedoe H; SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172-176.
42. Diez ROUX AV, Merkin SS, Arnett D, Chambless L, Massing M, Nieto FJ, Sorlie P, Szklo M, Tyroler HA, Watson RL. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99-106.
43. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335:136.
44. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart. 2008;94:34-39.
45. Kind AJ, Jencks S, Brock J, Yu M, Bartels C, Ehlenbach W, Greenberg C, Smith M. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161:765-774.
46. Willems S, De Maesschalck S, Deveugele M, Derese A, De Maeseneer J. Socioeconomic status of the patient and doctor-patient communication: does it make a difference? Patient Educ Couns. 2005;56:139-146.